Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Durect Corp (DRRX)

Durect Corp (DRRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Durect: Q3 Earnings Snapshot

Durect: Q3 Earnings Snapshot

DRRX : 0.9700 (+4.44%)
Durect: Q2 Earnings Snapshot

Durect: Q2 Earnings Snapshot

DRRX : 0.9700 (+4.44%)
Durect: Q1 Earnings Snapshot

Durect: Q1 Earnings Snapshot

DRRX : 0.9700 (+4.44%)
Durect: Q4 Earnings Snapshot

Durect: Q4 Earnings Snapshot

DRRX : 0.9700 (+4.44%)
Durect: Q3 Earnings Snapshot

Durect: Q3 Earnings Snapshot

DRRX : 0.9700 (+4.44%)
DURECT Corporation Announces Presentations in Upcoming Investor Conferences

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver...

DRRX : 0.9700 (+4.44%)
Durect: Q2 Earnings Snapshot

Durect: Q2 Earnings Snapshot

DRRX : 0.9700 (+4.44%)
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2023 and provided a corporate update....

DRRX : 0.9700 (+4.44%)
DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver...

DRRX : 0.9700 (+4.44%)
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the...

DRRX : 0.9700 (+4.44%)

Barchart Exclusives

Stocks Slip Before the Open as Bond Yields March Higher, U.S. Jobless Claims Data in Focus
March S&P 500 E-Mini futures (ESH25) are down -0.45%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.52% this morning as Treasury yields climbed after cash trading resumed following the Christmas holiday, with investors turning their attention to U.S. jobless claims numbers due later today. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar